NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests a combination of drugs (glofitamab, atezolizumab or polatuzumab vedotin, plus a single pre-treatment dose of obinutuzumab) in adults with B-cell non-Hodgkin's lymphoma that has come back or not responded to prior treatment. The goal is to find the safest dose and…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for lymphoma: drug cocktail targets Tough-to-Treat cancers
Disease control OngoingThis study is for Japanese adults with Non-Hodgkin lymphoma, a type of blood cancer. Researchers are testing a drug called tafasitamab, alone or combined with other medicines (lenalidomide, parsaclisib, or R-CHOP chemotherapy), to see if it is safe and helps shrink tumors. The st…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated May 22, 2026 14:02 UTC